|
Variables
|
LYRM4 mRNA expression
|
p value
|
Multivariate analysisa
|
|---|
|
Low (n = 79)
|
High (n = 78)
|
OR
|
95%
|
p value
|
|---|
|
Age, years
|
|
≤ 54
|
48
|
37
|
0.09
|
1
|
Reference
| |
|
> 54
|
31
|
41
| |
1.570
|
0.749–3.288
|
0.232
|
|
Gender
|
|
Male
|
62
|
65
|
0.44
|
1
|
Reference
| |
|
Female
|
17
|
13
| |
0.700
|
0.271–1.806
|
0.461
|
|
Preoperative AFP (ng/ml)
|
|
≤ 200
|
38
|
49
|
0.06
|
1
|
Reference
| |
|
> 200
|
40
|
28
| |
0.675
|
0.312–1.461
|
0.318
|
|
TB (µmol/L)
|
|
≤ 20
|
77
|
73
|
0.43
|
1
|
Reference
| |
|
> 20
|
2
|
5
| |
2.995
|
0.457–19.63
|
0.253
|
|
ALT (U/L)
|
|
≤ 50
|
50
|
60
|
0.91
|
1
|
Reference
| |
|
> 50
|
29
|
36
| |
0.405
|
0.170–0.968
|
0.042
|
|
γ-GT (U/L)
|
|
≤ 60
|
41
|
40
|
1.00
|
1
|
Reference
| |
|
> 60
|
38
|
37
| |
1.957
|
0.830–4.615
|
0.125
|
|
HBcAb
|
|
No
|
5
|
4
|
0.98
|
1
|
Reference
| |
|
Yes
|
74
|
74
| |
1.779
|
0.356–8.877
|
0.483
|
|
Tumor size (cm)
|
|
≤ 5
|
39
|
36
|
0.69
|
1
|
Reference
| |
|
> 5
|
40
|
42
| |
1.382
|
0.612–3.124
|
0.436
|
|
Tumor number
|
|
Single
|
58
|
58
|
0.89
|
1
|
Reference
| |
|
Multiple
|
21
|
20
| |
1.226
|
0.523–2.871
|
0.639
|
|
Tumor thrombus
|
|
No
|
55
|
66
|
0.03
|
1
|
Reference
| |
|
Yes
|
24
|
12
| |
0.355
|
0.132–0.957
|
0.041
|
|
Tumor encapsulation
|
|
No
|
27
|
17
|
0.08
|
1
|
Reference
| |
|
Yes
|
50
|
59
| |
2.345
|
1.035–5.315
|
0.041
|
|
Tumor differentiation
|
|
High
|
37
|
45
|
0.15
|
1
|
Reference
| |
|
Low
|
42
|
32
| |
0.771
|
0.368–1.618
|
0.492
|
|
History of liver cirrhosis
|
|
No
|
19
|
27
|
0.15
|
1
|
Reference
| |
|
Yes
|
60
|
51
| |
0.519
|
0.223–1.212
|
0.130
|
- Pearson Chi-Square test was used to analyze the relationship between LYRM4 mRNA expression and clinicopathological characteristics. Font bold means have statistical significance p < 0.05
- aLogistics regression was used to multivariate analysis
